# Fields Of Effects Of Two Commercial Preparations Of Botulinum Toxin Type A At Equal Labeled Unit Doses

> **NCT01732809** · PHASE4 · COMPLETED · sponsor: **Hexsel Dermatology Clinic** · enrollment: 19 (actual)

## Conditions studied

- Skin Wrinkling

## Interventions

- **DRUG:** AbobotulinumtoxinA (ABO)
- **DRUG:** OnabotulinumtoxinA (ONA)

## Key facts

- **NCT ID:** NCT01732809
- **Lead sponsor:** Hexsel Dermatology Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2020-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01732809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01732809, "Fields Of Effects Of Two Commercial Preparations Of Botulinum Toxin Type A At Equal Labeled Unit Doses". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01732809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*